Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women

NCT01989949 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Drug Tolerance

Interventions

DRUG: TP-434 (Eravacycline) reconstituted and administered via an IV infusion

Sponsor

Tetraphase Pharmaceuticals, Inc

Collaborators

[object Object]